Day: April 1, 2022

RAK Petroleum plc Releases 2021 Annual Report and Accounts

Written by Customer Service on April 1, 2022. Posted in Public Companies.

United Kingdom, 1 April 2022 RAK Petroleum plc, the Oslo-listed oil and gas investment company, today released its 2021 Annual Report and Accounts. A copy is attached and is available at http://www.rakpetroleum.uk/Investor-relations/Reports-and-presentations For further queries, please contact:Kevin TonerManaging DirectorRAK Petroleum plcEmail: kevin.toner@rakpetroleum.uk About RAK Petroleum plc RAK Petroleum plc is an Oslo Stock Exchange listed oil and gas investment company established under the laws of England and Wales as a public limited company. Its principal holdings are 44.94 percent of DNO ASA and 33.33 percent of Foxtrot International LDC held through Mondoil Enterprises, LLC. DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, DNO holds...

Logiq Closes Battle Bridge Acquisition

Written by Customer Service on April 1, 2022. Posted in Mergers And Acquisitions.

Strategic, Synergistic Transaction to Increase Market Share and Enhance Growth Opportunities Deal Expected to be Accretive to 2022 Earnings; Supports LGIQ Forecast for Breakeven EBITDA Run Rate by Year-EndNEW YORK, March 31, 2022 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ, NEO: LGIQ), a global provider of award-winning consumer acquisition solutions, today announced it has completed the acquisition of certain assets of the Battle Bridge Labs companies, including Section 2383 LLC (collectively, “Battle Bridge”), a Tulsa, Oklahoma-based digital brand marketing agency, on schedule, as previously announced February 17 as a binding LOI. Battle Bridge is a rapidly growing, leading boutique provider of digital brand marketing services including pay-per-click management, social media marketing, funnel creation and optimization, SEO,...

SEB Reports Fiscal Year 2021 Results

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

7 Quarters of Positive Adjusted EBITDA Conference Call Scheduled Monday April 4 at 3:30 P.M.Q4/21 revenue increased 13.7% year-over-year, with 2021 revenues finishing strong at $61.8 million Posted 7th consecutive quarter of positive adjusted EBITDA, growing full-year adjusted EBITDA by 27% to $2.3 million Exiting F2021 with 160,000 plan members in transition, with a large majority expected to contribute to the benefits business in 2022 Future revenue and EBITDA are expected to experience significant growth, driven by the Company’s strong business pipelineMISSISSAUGA, Ontario, March 31, 2022 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc. (“SEB” or the “Company”) (TSXV: SEB) (OTCQB: SEBFF) a benefits administration technology company providing leading-edge, cloud based end-to-end IT and benefit processing software solutions...

Medivolve Announces Q4 2021 Annual Results

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

The Company has included amended disclosures in its management discussion and analysis (“MD&A”) for the year ended December 31, 2021 to address comments received from the Ontario Securities Commission following a review of the Company’s continuous disclosure, including its MD&A for the interim period ended September 30, 2021 (“Q3 MD&A”). See “Continuous Disclosure” below.Revenue was $86,824,987 in the year ended December 31, 2021, up 720.4%, compared to $10,583,256 over the prior year ending December 30, 2020. Gross profit was $36,569,100 in the year ending December 31, 2021, up 693.9%, compared to $4,606,438 over the prior year ending December 30, 2020. Net loss was $6,610,524 in the year ending December 31, 2021, an improvement of 82.5%, compared to $37,777,656 over the prior year ending December 30, 2020.TORONTO,...

Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides a Business Update

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval Company Advances IP Portfolio With New Patent Applications Covering Novel Molecule Families DENVER, March 31, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results and provided a business update for the fiscal year ended December 31, 2021. “Last year, Mydecine made significant strides toward creating and commercializing new treatments for mental health and addiction disorders,” said CEO Josh Bartch. “The conditional IRB approval we received is yet another positive signal that we will continue to advance...

NXT Energy Solutions Announces 2021 Year-End Financial Results

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 31, 2022 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTC QB: NSFDF) today announced the Company’s financial and operating results for the year ended December 31, 2021. All dollar amounts herein are in Canadian Dollars unless otherwise identified. Financial and Operating Highlights Key financial and operational highlights include:the Company completed the 2021 advisory services and funding of $50,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) to support the research and development of the SFD® technology for geothermal applications; NXT announced that its patent application in India has been officially granted by the Office of the Controller General of Patents, Designs and...

CVW Cleantech Inc. Announces Appointment of Jennifer Kaufield to the Board of Directors

Written by Customer Service on April 1, 2022. Posted in Public Companies.

CALGARY, Alberta, March 31, 2022 (GLOBE NEWSWIRE) — CVW CleanTech Inc. (the “Company”) (TSX-V: CVW), is pleased to announce the appointment of Ms. Jennifer Kaufield to the Board of Directors (the “Board”), as an independent director of the Company. Ms. Kaufield was Vice President Finance and CFO of the company from February 2010 to June 2021. She is currently a non executive director of TransGlobe (TSX:TGL) and has over 30 years of experience in private and public corporations both domestic and international. Ms. Kaufield received her Bachelor of Administration, Accounting from St. Francis Xavier University and Chartered Accountant (CA) and Chartered Public Accounting (CPA) designations. “CVW is delighted to have attracted Jennifer back to the Company; her knowledge of the company and experience as...

SELLAS Life Sciences Announces Pricing of $25.0 Million Underwritten Public Offering

Written by Customer Service on April 1, 2022. Posted in Public Companies.

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the pricing of its previously announced underwritten public offering of 4,629,630 shares of its common stock and accompanying warrants to purchase up to 4,629,630 shares of common stock at a combined public offering price of $5.40 per share and accompanying warrant. The warrants to purchase shares of common stock have an exercise price of $5.40 per share, are immediately exercisable and will expire five years from the date of issuance. All of the securities in the offering will be sold by SELLAS, with gross proceeds to SELLAS expected to be $25.0 million before...

PyroGenesis Announces 2021 Results: Record Revenues $31.1MM; Gross Margin 40%; Record Current Backlog of Signed and/or Awarded Contracts $47.7MM

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

MONTREAL, March 31, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the fourth quarter and the fiscal year ended December 31st, 2021. “We are happy to be announcing our 2021 financial results, which includes both our exceptional organic growth plus the results of our recent acquisition, Pyro Green-Gas, (formerly AirScience Technologies Inc.). We have posted a series of record numbers for the company, which includes record revenues for a Q4 of $7.2MM – a revenue...

Novo Reports 2021 Financial Results

Written by Customer Service on April 1, 2022. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, March 31, 2022 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) is pleased to announce its financial results for the three and twelve-month periods ended December 31, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted. This news release should be read together with Novo’s management’s discussion and analysis (the “Annual MD&A”) and audited consolidated financial statements (the “Audited Financial Statements”) for the year ended December 31, 2021 (“Fiscal 2021”) and the eleven-month transitional period ended December 31, 2020 (“Fiscal 2020”) which are available under Novo’s profile on SEDAR (www.sedar.com). The fourth quarter of Fiscal 2021 is referred to as “Q4 2021” in this news release. HighlightsRevenue...

Day: April 1, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals